Bone density and alendronate effects in Duchenne muscular dystrophy patients

Houston C, Mathews K, Shibli-Rahhal A. Bone density and alendronate effects in Duchenne muscular dystrophy patients. Muscle & nerve 2014;49:506-11   Abstract INTRODUCTION: Patients with DMD have low bone mineral density (BMD) and are at high risk for fractures. We examined changes in BMD and the effects of alendronate in DMD patients treated at our […]